These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12118316)

  • 1. Normal ras genes: their onco-suppressor and pro-apoptotic functions (review).
    Spandidos DA; Sourvinos G; Tsatsanis C; Zafiropoulos A
    Int J Oncol; 2002 Aug; 21(2):237-41. PubMed ID: 12118316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFR, ErbB2 and Ras but not Src suppress RhoB expression while ectopic expression of RhoB antagonizes oncogene-mediated transformation.
    Jiang K; Delarue FL; Sebti SM
    Oncogene; 2004 Feb; 23(5):1136-45. PubMed ID: 14647415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of proto-oncogene activation in carcinogenesis.
    Anderson MW; Reynolds SH; You M; Maronpot RM
    Environ Health Perspect; 1992 Nov; 98():13-24. PubMed ID: 1486840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear localization is essential for the activity of p53 protein.
    Shaulsky G; Goldfinger N; Tosky MS; Levine AJ; Rotter V
    Oncogene; 1991 Nov; 6(11):2055-65. PubMed ID: 1719467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The N-ras proto-oncogene can suppress the malignant phenotype in the presence or absence of its oncogene.
    Diaz R; Ahn D; Lopez-Barcons L; Malumbres M; Perez de Castro I; Lue J; Ferrer-Miralles N; Mangues R; Tsong J; Garcia R; Perez-Soler R; Pellicer A
    Cancer Res; 2002 Aug; 62(15):4514-8. PubMed ID: 12154063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-kappa B is required for H-ras oncogene induced abnormal cell proliferation and tumorigenesis.
    Jo H; Zhang R; Zhang H; McKinsey TA; Shao J; Beauchamp RD; Ballard DW; Liang P
    Oncogene; 2000 Feb; 19(7):841-9. PubMed ID: 10702792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The retinoblastoma protein is required for Ras-induced oncogenic transformation.
    Williams JP; Stewart T; Li B; Mulloy R; Dimova D; Classon M
    Mol Cell Biol; 2006 Feb; 26(4):1170-82. PubMed ID: 16449633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The wild-type Ras: road ahead.
    Singh A; Sowjanya AP; Ramakrishna G
    FASEB J; 2005 Feb; 19(2):161-9. PubMed ID: 15677339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of PTEN expression is essential for antiapoptosis and cellular transformation by oncogenic Ras.
    Vasudevan KM; Burikhanov R; Goswami A; Rangnekar VM
    Cancer Res; 2007 Nov; 67(21):10343-50. PubMed ID: 17974977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Fas (CD95) expression and Fas-mediated apoptosis by oncogenic Ras.
    Fenton RG; Hixon JA; Wright PW; Brooks AD; Sayers TJ
    Cancer Res; 1998 Aug; 58(15):3391-400. PubMed ID: 9699671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-apoptotic activity of oncogenic H-Ras for histone deacetylase inhibitor to induce apoptosis of human cancer HT29 cells.
    Choudhary S; Wang HC
    J Cancer Res Clin Oncol; 2007 Oct; 133(10):725-39. PubMed ID: 17487507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic Ras sensitizes normal human cells to tumor necrosis factor-alpha-related apoptosis-inducing ligand-induced apoptosis.
    Nesterov A; Nikrad M; Johnson T; Kraft AS
    Cancer Res; 2004 Jun; 64(11):3922-7. PubMed ID: 15173003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay between oncogenic K-Ras and wild-type H-Ras in Caco2 cell transformation.
    Ikonomou G; Kostourou V; Shirasawa S; Sasazuki T; Samiotaki M; Panayotou G
    J Proteomics; 2012 Sep; 75(17):5356-69. PubMed ID: 22800643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immortalized fibroblasts from NF-kappaB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor alpha after transformation by v-Ras.
    Gapuzan ME; Schmah O; Pollock AD; Hoffmann A; Gilmore TD
    Oncogene; 2005 Sep; 24(43):6574-83. PubMed ID: 16027734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wild-type p53 can inhibit oncogene-mediated focus formation.
    Eliyahu D; Michalovitz D; Eliyahu S; Pinhasi-Kimhi O; Oren M
    Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8763-7. PubMed ID: 2530586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The K-ras gene regulates vascular endothelial growth factor gene expression in non-small cell lung cancers.
    Konishi T; Huang CL; Adachi M; Taki T; Inufusa H; Kodama K; Kohno N; Miyake M
    Int J Oncol; 2000 Mar; 16(3):501-11. PubMed ID: 10675482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of apoptosis by tamoxifen-activation of a p53-estrogen receptor fusion protein expressed in E1A and T24 H-ras transformed p53-/- mouse embryo fibroblasts.
    Vater CA; Bartle LM; Dionne CA; Littlewood TD; Goldmacher VS
    Oncogene; 1996 Aug; 13(4):739-48. PubMed ID: 8761295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human retinoblastoma gene product prevents c-Ha-ras oncogene mediated cellular transformation of mouse fibroblasts.
    Kivinen L; Pitkänen K; Laiho M
    Oncogene; 1993 Oct; 8(10):2703-11. PubMed ID: 8378082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of PKC causes oncogenic stress for triggering apoptosis in cancer cells.
    Ganapathy S; Peng B; Shen L; Yu T; Lafontant J; Li P; Xiong R; Makriyannis A; Chen C
    Oncotarget; 2017 May; 8(19):30992-31002. PubMed ID: 28415683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.